CA3000495A1 – October 6, 2019 – PHARMACEUTICAL COMPOSITIONS CONTAINING CANNABIS, USES THEREOF AND METHODS FOR IMPROVING ENERGY LEVELS AND/OR ALLEVIATING FATIGUE

Please complete the required fields.




Inventors :

NIJHAWAN, PARDEEP - 34 BERNADOTTE DR

Owner :

EXZELL PHARMA INC.

Application Number :

CA3000495

Document Number :

CA3000495A1

Priority Date :

April 6, 2018

Filing Date :

April 6, 2018

Date of Grant/ Publication :

October 6, 2019

Class :

A61K36 / 185; A61K31 / 05; A61K31 / 192; A61K31 / 352; A61K31 / 519; A61K31 / 7004; A61K31 / 714; A61K36 / 77; A61K36 / 82

Abstract

A pharmaceutical composition containing cannabis for increasing energy levels and/or alleviating fatigue in a patient. Also provided are a use of the pharmaceutical composition for increasing energy levels and/or alleviating fatigue in a patient, and methods for increasing energy levels and/or alleviating fatigue. The pharmaceutical composition preferably includes a combination of therapeutically effective amounts of one or more of the following medicinal ingredients: cannabis, an herb, vitamins, and/or fructose.

Claim(s)

claim 1: 1 . A pharmaceutical composition for increasing energy levels and/or alleviating fatigue in a patient comprising a therapeutically effective amount of cannabis, an herb, vitamins, fructose and pharmaceutically acceptable excipients.;
claim 2: 2 . The pharmaceutical composition of claim 1 , wherein the cannabis is selected from the group consisting of: cannabidiol (CBD), cannabidiol acid (CBDA), cannabinol (CBN), cannabigerol (CBG), cannabigerol acid (CBGA), cannabidivarin (CBDV), cannabidivarin acid (CBDVA), cannabinovarin (CBNV), cannabigerovarin (CBGV), cannabichromene (CBC), a naphthoylindole, a phenylacetylindole, a benzoylindole, a cyclohexylphenole, delta-9 tetrahydrocannabinol (THC or dronabinol), delta-8 tetrahydrocannabinol (D8-THC), tetrahydrocannabinol acid (THCA), tetrahydrocannabivarin (THCV), tetrahydrocannabivarin acid (THCVA), the pharmaceutical agent is CBD, THC or combinations thereof.;
claim 3: 3 . The pharmaceutical composition of claim 2 , wherein the herb is selected from the group consisting of: Camellia sinensis; Paullinia cupana ; and combinations thereof.;
claim 4: 4 . The pharmaceutical composition of claim 3 comprising: Camellia sinensis from about 10 mg to about 500 mg per dose; and Paullinia cupana from about 25 mg to about 1000 mg per dose.;
claim 5: 5 . The pharmaceutical composition of claim 3 comprising: Camellia sinensis from about 100 mg to about 200 mg per dose; and Paullinia cupana from about 100 mg to about 200 mg per dose.;
claim 6: 6 . The pharmaceutical composition of claim 5 , wherein the vitamin is selected from the group consisting of: Vitamin B9 (Folate); Vitamin B12 (Cobalamin); and combinations thereof.;
claim 7: 7 . The pharmaceutical composition of claim 6 comprising: Vitamin B9 (Folate) from about 25 mcg to about 2000 mcg per dose; and Vitamin B12 (Cobalamin) from about 250 mcg to about 2000 mcg per dose.;
claim 8: 8 . The pharmaceutical composition of claim 6 comprising: Vitamin B9 (Folate) from about 250 mcg to about 400 mcg per dose; and Vitamin B12 (Cobalamin) from about 450 mcg to about 550 mcg per dose.;
claim 9: 9 . The pharmaceutical composition of claim 8 , wherein the fructose is from about 25 mg to about 100 mg per dose.;
claim 10: 10 . The pharmaceutical composition of claim 8 , wherein the fructose is from about 30 mg to about 70 mg per dose.;
claim 11: 11 . The pharmaceutical composition of claim 10 , wherein the cannabis comprises from about 1 to about 30 mg of cannabinoid per dose.;
claim 12: 12 . The pharmaceutical composition of claim 10 , wherein the cannabis comprises from about 2.5 mg to about 10 mg of cannabinoid per dose.;
claim 13: 13 . Use of a pharmaceutical composition comprising a therapeutically effective amount of cannabis, an herb, a vitamin, fructose and pharmaceutically acceptable excipients for increasing energy levels and/or alleviating fatigue in a patient.;
claim 14: 14 . A method for increasing energy levels and/or alleviating fatigue in a patient comprising administering to the patient, in one or more doses, a pharmaceutical composition comprising a therapeutically effective amount of cannabis, an herb, a vitamin, fructose and pharmaceutically acceptable excipients.

Summary

No Comments

Leave a comment

Sorry, you must be logged in to post a comment. Login